| Home > Articles > Published articles > Validity of a method for the self-screening of cardiovascular risk |
| Date: | 2018 |
| Abstract: | The validity of a cardiovascular risk self-screening method was assessed. The results obtained for self-measurement of blood pressure, a point-of-care system's assessment of lipid profile and glycated hemoglobin, and a self-administered questionnaire (sex, age, diabetes, tobacco consumption) were compared with the standard screening (gold standard) conducted by a health professional. Crossover clinical trial on a population-based sample from Girona (north-eastern Spain), aged 35-74, with no cardiovascular disease at recruitment. Participants were randomized to one of the two risk assessment sequences (standard screening followed by self-screening or vice versa). Cardiovascular risk was estimated with the Framingham-REGICOR function. Concordance between methods was estimated with the intraclass correlation coefficient (ICC). Sensitivity, specificity, and positive and negative predictive values were estimated, considering 5% cardiovascular risk as the cutoff point. Registration #NCT02373319. Clinical Research Ethic Committee of the Parc de Salut Mar Registration #2014/5815/I. The median cardiovascular risk in men was 2. 56 (interquartile range: 1. 42-4. 35) estimated by standard methods and 2. 25 (1. 28-4. 07) by self-screening with ICC=0. 92 (95% CI: 0. 90-0. 93). In women, the cardiovascular risk was 1. 14 (0. 61-2. 10) by standard methods and 1. 10 (0. 56-2. 00) by self-screening, with ICC=0. 89 (0. 87-0. 90). The sensitivity, specificity, and positive and negative predictive values for the self-screening method were 0. 74 (0. 63-0. 82), 0. 97 (0. 95-0. 99), 0. 86 (0. 77-0. 93), and 0. 94 (0. 91-0. 96), respectively, in men. In women, these values were 0. 50 (0. 30-0. 70), 0. 99 (0. 98-1), 0. 81 (0. 54-0. 96), and 0. 97 (0. 95-0. 99), respectively. The self-screening method for assessing cardiovascular risk provided similar results to the standard method. Self-screening had high clinical performance to rule out intermediate or high cardiovascular risk. |
| Grants: | Instituto de Salud Carlos III CM12/03287 Instituto de Salud Carlos III CPII17/00012 Instituto de Salud Carlos III FIS14/00449 |
| Rights: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. |
| Language: | Anglès |
| Document: | Article ; Versió publicada |
| Subject: | Risk assessment ; Cardiovascular diseases ; Preventive medicine ; Public health ; Epidemiology ; Empowerment |
| Published in: | Clinical Epidemiology, Vol. 10 (may 2018) , p. 549-560, ISSN 1179-1349 |
12 p, 1.8 MB |